| P2093 | author name string | Robert J Fontana | |
| P2860 | cites work | A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation. Canadian Critical Care Trials Group | Q74319356 |
| | Cerebral herniation in patients with acute liver failure is correlated with arterial ammonia concentration | Q74529902 |
| | Alpha-fetoprotein and prognosis in acute liver failure | Q79390852 |
| | A randomized controlled trial of lamivudine to treat acute hepatitis B | Q79449890 |
| | Drug-induced liver injury network (DILIN) | Q80594548 |
| | MELD/PELD and the allocation of deceased donor livers for status 1 recipients with acute fulminant hepatic failure, primary nonfunction, hepatic artery thrombosis, and acute Wilson's disease | Q80594778 |
| | The need for a population-based surveillance system for liver disease in the United States | Q80867527 |
| | Moderate hypothermia in patients with acute liver failure and uncontrolled intracranial hypertension | Q80947614 |
| | Attempting to predict the unpredictable in acute liver injury | Q81223826 |
| | Clinical outcome and virological characteristics of hepatitis B-related acute liver failure in the United States | Q81419310 |
| | Controlled trial of exchange-transfusion therapy in fulminant hepatitis | Q93731472 |
| | Acetaminophen-induced hepatotoxicity | Q28185453 |
| | A practice guideline on Wilson disease | Q28207512 |
| | Early indicators of prognosis in fulminant hepatic failure: an assessment of the King's criteria | Q28237954 |
| | Early indicators of prognosis in fulminant hepatic failure | Q28241473 |
| | AASLD position paper: the management of acute liver failure | Q28246028 |
| | Maternal and perinatal outcome in severe pregnancy-related liver disease | Q28254029 |
| | Amanita poisoning: treatment and the role of liver transplantation | Q28268140 |
| | Improvement by acetylcysteine of hemodynamics and oxygen transport in fulminant hepatic failure | Q28333321 |
| | Effects of legislation restricting pack sizes of paracetamol and salicylate on self poisoning in the United Kingdom: before and after study | Q28365305 |
| | Recombinant activated factor VII for coagulopathy in fulminant hepatic failure compared with conventional therapy | Q30310461 |
| | Recombinant activated factor VII (rFVIIa) as a hemostatic agent in liver disease: a break from convention in need of controlled trials | Q30312208 |
| | Acetylcysteine treatment for non-acetaminophen-induced acute liver failure | Q31038008 |
| | Thrombocytopenic disorders in critically ill patients | Q33333476 |
| | Syndrome of hemolysis, elevated liver enzymes, and low platelet count: a severe consequence of hypertension in pregnancy | Q33484095 |
| | The natural history of histologically proved drug induced liver disease | Q33594865 |
| | Herpes simplex hepatitis in pregnancy: a case report and review of the literature | Q33679944 |
| | A fetal fatty-acid oxidation disorder as a cause of liver disease in pregnant women | Q33863717 |
| | Treating Budd-Chiari Syndrome: making rational choices from a myriad of options | Q33871650 |
| | Controlled trials of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure. | Q51772704 |
| | Etiology and outcome for 295 patients with acute liver failure in the United States. | Q52907526 |
| | Hyperventilation restores cerebral blood flow autoregulation in patients with acute liver failure | Q53501226 |
| | Immunological alterations in pregnant women with acute hepatitis E. | Q54659042 |
| | Functional loss of cerebral blood flow autoregulation in patients with fulminant hepatic failure | Q57396307 |
| | Acute Budd-Chiari syndrome with fulminant hepatic failure in a pregnant woman with factor V Leiden mutation | Q58455499 |
| | Aetiology and prognostic factors in acute liver failure in India | Q59829991 |
| | Drug-Induced Liver Injury: An Analysis of 461 Incidences Submitted to the Spanish Registry Over a 10-Year Period | Q60344407 |
| | Comparison of two clinical scales for causality assessment in hepatotoxicity | Q60344692 |
| | A double-blinded, randomized trial of hydrocortisone in acute hepatic failure. The Acute Hepatic Failure Study Group | Q67700092 |
| | A controlled trial of steroid therapy in massive hepatic necrosis | Q69356682 |
| | Improved cardiovascular stability during continuous modes of renal replacement therapy in critically ill patients with acute hepatic and renal failure | Q70577486 |
| | Acute hepatic necrosis with stupor or coma. An analysis of thirty-one patients | Q72366018 |
| | Histopathological heterogeneity in fulminant hepatic failure | Q72511213 |
| | Clinical and radiologic features of cerebral edema in fulminant hepatic failure | Q72518939 |
| | Timing and aetiology of bacterial infections in a liver intensive care unit | Q72998558 |
| | Fulminant hepatic failure: observation with serial CT | Q73028360 |
| | Prognostic value of abdominal CT scanning and hepatic histopathology in patients with acute liver failure | Q73534884 |
| | Hepatitis B infection in patients with acute liver failure in the United States | Q73704479 |
| | Subclinical seizure activity and prophylactic phenytoin infusion in acute liver failure: a controlled clinical trial | Q74228244 |
| | Acute liver failure in children: the first 348 patients in the pediatric acute liver failure study group | Q37142641 |
| | UK legislation on analgesic packs: before and after study of long term effect on poisonings | Q37603540 |
| | Acetaminophen toxicity in an urban county hospital | Q39454333 |
| | Incidence of drug-induced hepatic injuries: a French population-based study | Q39609276 |
| | Complications and use of intracranial pressure monitoring in patients with acute liver failure and severe encephalopathy | Q40369307 |
| | Herpes simplex virus-associated acute liver failure: a difficult diagnosis with a poor prognosis | Q40492767 |
| | Fulminant hepatic failure: summary of a workshop | Q40560163 |
| | Acute liver failure due to lymphoma. A diagnostic concern when considering liver transplantation | Q40761040 |
| | Causality assessment of adverse reactions to drugs--I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries | Q40775438 |
| | Acute liver failure due to hepatic involvement by hematologic malignancy | Q41552368 |
| | Emergency liver transplantation for acute liver failure. Evaluation of London and Clichy criteria | Q42068035 |
| | Thiopental infusion in the treatment of intracranial hypertension complicating fulminant hepatic failure. | Q42198735 |
| | Earlier identification of patients at risk from acetaminophen-induced acute liver failure | Q42545008 |
| | Liver transplantation for acute liver failure from drug induced liver injury in the United States | Q42636770 |
| | "Unintentional" acetaminophen overdose on the rise: who is responsible? Dr Robert J Fontana is interviewed by Paul C Adams | Q43157715 |
| | Restoration of cerebral blood flow autoregulation and reactivity to carbon dioxide in acute liver failure by moderate hypothermia | Q43657677 |
| | Effect of maximal daily doses of acetaminophen on the liver of alcoholic patients: a randomized, double-blind, placebo-controlled trial | Q43750040 |
| | Outcomes following liver transplantation for seronegative acute liver failure: experience during a 12-year period with more than 100 patients | Q43835620 |
| | Effect of lidocaine on ICP response to endotracheal suctioning | Q43951290 |
| | Severe hepatotoxicity associated with the dietary supplement LipoKinetix | Q43960354 |
| | Acetaminophen hepatotoxicity: the first 35 years | Q43979608 |
| | Serum phosphate is an early predictor of outcome in severe acetaminophen-induced hepatotoxicity | Q44116636 |
| | Varicella-zoster virus infection associated with acute liver failure. | Q44297146 |
| | Efficacy of superactivated charcoal administered late (3 hours) after acetaminophen overdose | Q44481367 |
| | High prevalence of potentially hepatotoxic herbal supplement use in patients with fulminant hepatic failure | Q44545437 |
| | Viral and clinical factors associated with the fulminant course of hepatitis A infection | Q44562450 |
| | Infection and the progression of hepatic encephalopathy in acute liver failure | Q44569532 |
| | Worsening of cerebral hyperemia by the administration of terlipressin in acute liver failure with severe encephalopathy. | Q44759297 |
| | MELD score as a predictor of pretransplant and posttransplant survival in OPTN/UNOS status 1 patients | Q44785876 |
| | Acetaminophen hepatoxicity: what do we know, what don't we know, and what do we do next? | Q44967726 |
| | Treatment of fulminant hepatic failure with intravenous prostaglandin E1. | Q45113360 |
| | Lamivudine treatment for acute severe hepatitis B: a pilot study | Q45164425 |
| | Prediction of survival for patients with fulminant hepatic failure | Q45250496 |
| | Alpha-fetoprotein is a predictor of outcome in acetaminophen-induced liver injury | Q45250499 |
| | Brief report: no evidence for parvovirus B19 or hepatitis E virus as a cause of acute liver failure | Q45412339 |
| | Investigation of SEN Virus Infection in Patients with Cryptogenic Acute Liver Failure, Hepatitis‐Associated Aplastic Anemia, or Acute and Chronic Non–A–E Hepatitis | Q45709231 |
| | Measurement of serum acetaminophen-protein adducts in patients with acute liver failure | Q46051738 |
| | Acute fatty liver of pregnancy: a clinicopathologic study of 35 cases | Q46378831 |
| | The Prometheus device for extracorporeal support of combined liver and renal failure | Q46568510 |
| | Estimates of acetaminophen (Paracetomal)-associated overdoses in the United States | Q46809738 |
| | Drug-induced liver injury: summary of a single topic clinical research conference | Q46959086 |
| | Clinical characteristics and prognostic indicators of drug-induced fulminant hepatic failure | Q47430261 |
| | Cerebral and cardiovascular responses to changes in head elevation in patients with intracranial hypertension | Q48709574 |
| | Association of acetaminophen hepatotoxicity with fasting and ethanol use. | Q51592407 |
| | Safety and efficacy of a recombinant hepatitis E vaccine | Q34002701 |
| | Efficacy of oral N-acetylcysteine in the treatment of acetaminophen overdose. Analysis of the national multicenter study (1976 to 1985) | Q34048790 |
| | Blood lactate as an early predictor of outcome in paracetamol-induced acute liver failure: a cohort study | Q34116063 |
| | Propofol to control intracranial pressure in fulminant hepatic failure | Q34134077 |
| | Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States | Q34165115 |
| | Model for end-stage liver disease (MELD) and allocation of donor livers | Q34168541 |
| | Herpes simplex-induced fulminant hepatitis in adults: a call for empiric therapy | Q34189847 |
| | Moderate hypothermia prevents cerebral hyperemia and increase in intracranial pressure in patients undergoing liver transplantation for acute liver failure | Q34209449 |
| | Drug-induced hepatotoxicity. | Q34218613 |
| | Hepatotoxicity associated with acetaminophen usage in patients receiving multiple drug therapy for tuberculosis | Q34291085 |
| | The effect of hypertonic sodium chloride on intracranial pressure in patients with acute liver failure | Q34295388 |
| | Acetaminophen (paracetamol) hepatotoxicity with regular intake of alcohol: Analysis of instances of therapeutic misadventure | Q34303815 |
| | Prospective, randomized, multicenter, controlled trial of a bioartificial liver in treating acute liver failure. | Q34313335 |
| | Outcome and prognostic markers in severe drug-induced liver disease | Q34434766 |
| | Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period | Q34440712 |
| | Mushroom poisoning--from diarrhea to liver transplantation | Q34448068 |
| | Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study | Q34471434 |
| | Renal failure in fulminant hepatic failure and terminal cirrhosis: a comparison between incidence, types, and prognosis | Q34493923 |
| | Controlled trial of dexamethasone and mannitol for the cerebral oedema of fulminant hepatic failure | Q34495241 |
| | Wilson's disease: clinical presentation and use of prognostic index | Q34531677 |
| | Aminotransferase elevations in healthy adults receiving 4 grams of acetaminophen daily: a randomized controlled trial | Q34544702 |
| | Paracetamol-induced acute renal failure in the absence of fulminant liver damage. | Q34745120 |
| | Haemostatic abnormalities in patients with liver disease | Q34749870 |
| | New Liver Support Devices in Acute Liver Failure: A Critical Evaluation | Q35549241 |
| | What is the rate of adverse events after oral N-acetylcysteine administered by the intravenous route to patients with suspected acetaminophen poisoning? | Q35591671 |
| | Fulminant hepatic failure as the initial presentation of acute autoimmune hepatitis | Q35821399 |
| | Recognizing drug-induced liver injury: current problems, possible solutions | Q36086434 |
| | Pathophysiological basis of therapy of raised intracranial pressure in acute liver failure | Q36145983 |
| | Hepatic assist devices. | Q36178218 |
| | Fulminant hepatitis A virus infection in the United States: Incidence, prognosis, and outcomes | Q36421177 |
| | Acute liver failure induced by green tea extracts: case report and review of the literature. | Q36667898 |
| | Liver transplantation for status 1: the consequences of good intentions. | Q36801201 |
| | Causality assessment of drug-induced hepatotoxicity: promises and pitfalls | Q36920981 |
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | liver failure | Q970208 |
| | drug overdose | Q3505252 |
| | paracetamol | Q57055 |
| P304 | page(s) | 761-94, viii | |
| P577 | publication date | 2008-07-01 | |
| P1433 | published in | Medical Clinics of North America | Q15761972 |
| P1476 | title | Acute liver failure including acetaminophen overdose | |
| P478 | volume | 92 | |